Good morning, everyone, and nice to see you again. We were preoccupied yesterday with a panel engagement — these occur from time to time — but have now returned to the usual routine, as you can see. And what a routine it is. Deadlines, meetings, and whatnot are piling up quickly. No doubt, you can relate. So please join us as we cope with a few cups of stimulation. And of course, here are your tidbits. Have a smashing day and do keep in touch …
Johnson & Johnson raised the list prices on its drugs by an average of 8.5 last year — and 3.5 percent after paying rebates and discounts, according to this report. List prices increased an average of 9.7 percent in 2015, 8.3 percent in 2014, and 9 percent in 2013. The disclosure was the latest by a big drug maker to explain pricing trends to an angry public, although Johnson & Johnson did not provide breakdowns by product.
About the Author Reprints
